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ABSTRACT 
Human breath is a concoction of thousands of compounds having in it a 
breath-print of physiological processes in the body. Though breath provides a 
non-invasive and easy to handle biological fluid, its analysis for clinical diagnosis 
is not very common. Partly the reason for this absence is unavailability of cost 
effective and convenient tools for such analysis. Scientific literature is full of 
novel sensor ideas but it is challenging to develop a working device, which are 
few. These challenges include trace level detection, presence of hundreds of 
interfering compounds, excessive humidity, different sampling regulations and 
personal variability.  
To meet these challenges as well as deliver a low cost solution, optical 
sensors based on specific colorimetric chemical reactions on mesoporous 
membranes have been developed. Sensor hardware utilizing cost effective and 
ubiquitously available light source (LED) and detector (webcam/photo diodes) 
has been developed and optimized for sensitive detection. Sample conditioning 
mouthpiece suitable for portable sensors is developed and integrated. The sensors 
are capable of communication with mobile phones realizing the idea of m-health 
for easy personal health monitoring in free living conditions.  
Nitric oxide and Acetone are chosen as analytes of interest. Nitric oxide 
levels in the breath correlate with lung inflammation which makes it useful for 
asthma management. Acetone levels increase during ketosis resulting from fat 
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metabolism in the body. Monitoring breath acetone thus provides useful 
information to people with type1 diabetes, epileptic children on ketogenic diets 
and people following fitness plans for weight loss. 
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1 
INTRODUCTION 
Clinical diagnosis is based on inferences that are drawn on information collected 
about our body in a diseased condition or otherwise. With advancements in molecular 
diagnostics we are no more limited to just physical examination to tell us the story. 
Biological fluids are very routinely analyzed in a clinical laboratory to aid in diagnosis 
and narrow down to specific conclusions. The main focus of the biochemical and 
biomolecular diagnostic methods which have developed very rapidly in past few decades 
has been on blood and urine analysis. Considering that medical diagnosis is driven by 
information, it becomes important to consider all available sources of information.   
Breath is another biological fluid which has not been exploited to its full potential 
for clinical diagnosis. A question that may be asked at this point is that given all the 
advances made in blood and urine analysis, do we gain any new information out of breath 
analysis? Blood or urine tests are usually concerned with large molecules which are non-
volatile in nature such as proteins and other macromolecules. Low molecular weight 
volatile compounds are usually lost in sampling. However, it is now evident that many of 
these volatile compounds are found in exhaled breath even though they are in trace 
concentrations of parts per million (ppm) or parts per billion (ppb) by volume [3]. Many 
of these compounds, when quantitatively measured, can give us information for 
appropriate diagnosis [4].  
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Apart from having information that is not available by routine blood and urine 
analysis, breath analysis is also attractive because it is a non-invasive procedure [5]. It is 
more agreeable to patients over blood sampling which is invasive and considered painful 
and also over urine sampling due to convenience of sample availability which avoids 
embarrassment to the patient [6]. Breath samples have successfully been collected from a 
range of subjects including neonates [7], conscious two year old children [8], critically ill 
patients [9], and patients with Alzheimer’s and Parkinson’s disease [10]. 
With all the potentials of clinical diagnostics and ease of sample access, exhaled 
breath analysis has attracted attentions of scientists and engineers. Even though a lot of 
work has been done in recent past, using breath for diagnosis is not a new concept. 
Historically, ancient Greek and Chinese medical texts have associated unique breath 
smells with physiological disorders or diseases. Likewise, breath smells of patients with 
uncontrolled diabetes are often described as rotten apple like due to high acetone levels in 
their breath, failing kidneys can lead to urine-like smell in the breath due to ammonia 
buildup, patients with lung abscesses may have sewer like smell in their breath due to 
proliferation of anaerobic bacteria, and a fishy reek smell may be the result of a liver 
disease [11-13]. The limitation of relying on breath smell for diagnosis is that diseases 
can only be diagnosed at a very advanced stage when systemic metabolism has been 
totally compromised. 
Today, a lot more is known both qualitatively and quantitatively about the 
exhaled breath. With advancement in analytical techniques, several studies have 
contributed to our understanding of breath as a complex mixture of gases. Starting from 
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Lavoisier who analyzed exhaled breath and reported the first quantitative analysis of 
carbon dioxide in 1784 to various modern pioneering works from Pauling [14], Larson 
[15], Chen [16], Riely [17], Phillips [18] and others have helped to identify more than 
3,500 different components in exhaled breath. The composition of exhaled breath is now 
identified as a mixture of inorganic gases (e.g. NO, CO2 and CO), volatile organic 
compounds (VOCs) (e.g. isoprene, ethane, pentane, and acetone), and other typically 
nonvolatile substances (e.g. isoprostanes, peroxynitrite, cytokines and nitrogen). 
Since these components are of endogenous and also exogenous origin, they carry 
signatures of various physiological processes that take place in the body [3, 19] and also 
can reflect one’s environmental exposure.  This signature has been referred to as breath 
print in the literature [10, 20]. Many studies have been done to understand the origin of 
these gases in exhaled breath or to correlate their quantitative levels to certain 
physiological states. The understanding of this breath print in individuals or populations 
aims to establish either the presence or changes in concentrations of some of the exhaled 
components as markers for diagnosis and/or monitoring of our health or monitoring the 
therapy administered under diseased conditions. 
United States Federal Drug Administration (FDA) has approved breath testing for 
monitoring blood alcohol using breath ethanol, asthma using exhaled nitric oxide, 
neonate jaundice using exhaled carbon monoxide, testing for Helicobacter pylori 
infection using exhaled carbon dioxide, carbohydrate metabolism using hydrogen and 
organ transplant rejection using exhaled branched hydrocarbons. This list will hopefully 
grow rapidly as more and more pilot studies are being done to establish changes in some 
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other breath components as indicative of diseases. For example, acetone levels are seen 
elevated in diabetes [21], higher ammonia levels indicate kidney and liver dysfunction 
[22, 23], and saturated hydrocarbon levels can be used to monitor the degree of oxidative 
stress [24, 25]. 
To gain further knowledge about how breath reflects our health is an important 
task at hand but equally important is to develop tools which will allow us to use the 
knowledge already available to the field of breath research in monitoring health, fitness 
and therapies in a facile and economical manner. Several tools available for breath 
analysis include gas chromatography coupled with mass spectrometry (GC-MS) or flame 
ionization detection (GC-FID), Selected Ion Flow Tube mass spectrometry (SIFT-MS), 
Chemiluminescence detection, Laser spectroscopy, and electrochemical sensors. Many of 
these tools though are very accurate, do not go beyond a laboratory or clinical setting 
because they are either very expensive, bulky, or need expertise for operation. 
To utilize breath as a tool for monitoring of health and fitness, people should be 
empowered with sensor devices that can come out of a standard laboratory or clinical 
setting and be used on a regular basis. For this reason, ideas from mobile health 
technologies popularly known as m-health have inspired development of the sensors 
presented in this thesis. The term m-health, coined by Prof. Robert Istepania, is referred 
to as “emerging mobile communications and network technologies for healthcare 
systems” in his book M-Health: Emerging Mobile Health Systems [26] and it was 
defined as “the delivery of healthcare services via mobile communication devices” at the 
2010 mHealth Summit of the Foundation for the National Institutes of Health [27]. 
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Modern health care faces several challenges in terms of rising costs, increasing demand, 
lack of trained health care professionals and facilities, poor reach in remote areas and 
limited financial resources [28]. Under these constrains it becomes important to look up 
to development in other technological areas for solutions. Mobiles phones have become 
ubiquitous not only in developed countries but in many developing countries too [29]. 
Their penetration into remote areas present a unique opportunity for delivering health 
care to inaccessible places utilizing capabilities of information technology [30]. Internet 
enabled smart phones take it to the next level where phones are not only limited to 
delivering information but can be used to communicate with external devices, process 
large chunks of data, present processed results to the user or a health care professional, 
create cloud accessible logs, and be remotely updated. Thus, m-health promises to 
provide solutions for ubiquitous monitoring of health in rural or urban free living 
conditions which would help in better health management of the users, regular 
monitoring also would help reduce emergency health situations by providing timely 
alarm to impending health issues. Many efforts to exploit the potentials of m-health have 
been made. Many physical sensors have been integrated with mobile phones. These can 
read EEG and ECG signal using electrodes [31-34], movement using accelerometers 
[35], blood oxygen levels and heart rates using optical detection [36], calorie intake using 
phone’s inbuilt cameras [37, 38], and offer health related motivational and educational 
games [39, 40]. Chemical sensors are not as popular in m-health domain except some 
electrochemical sensors for blood glucose measurements [41, 42]. This is mainly because 
miniaturization and then integration of chemical sensors with mobile technologies is 
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challenging. This becomes even more difficult with breath sensors. To meet these 
requirements there are several characteristics that such a sensor should have. It should 
have a sensitive detection to monitor trace gases because several compounds of interest 
are only available in ppb or ppm levels by volume in the breath. Breath being a complex 
mixture of thousands of trace gases also requires the sensor to be selective towards the 
component to be analyzed. If confounded, either by other trace gases or components in 
high concentrations like oxygen, carbon dioxide, and water vapors, the sensor is rendered 
useless. There should be facility for consistent breath sample delivery and conditioning of 
the sample. Many times, the breath sensors cannot be made immune to all the interfering 
components. Even if the detection is specific, high amount of water vapors condensed in 
the sampling line or sensor surface can lead to either confounding, blockage, or noise in 
the signal. There are also situations in which the components as such cannot be detected 
but are detectable after certain preconditioning. For example, oxidation, reduction, or 
conversion to other forms by a suitable chemical reaction.  Appropriate measures should 
be included in the device to precondition the sample before analysis in order to avoid 
these issues encountered during online sampling. The sensor device, if targeted towards 
use by people in general should also be small. The question one may ask is, how small is 
small? Of course, it depends on the usage. Considering the application to be regular 
monitoring of health in a free living condition not confined to hospitals, a wearable size 
would be most appropriate. Also the cost of such a sensor device would play a role in 
deciding its reach to people. Though certain critically ill patients who would need regular 
monitoring on an urgent basis may justify high spending on such a device, in many other 
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cases where monitoring is needed but is not urgent, high cost may be a deterrent. An 
expensive device may not at all be affordable to many people who may be in urgent need 
of monitoring. Certainly, available tools which cost from few thousand dollars in case of 
electrochemical sensors to above hundred thousand dollars in case of SIFT-MS are not 
easily affordable. Also cost per test and the maintenance required are important factors. 
The lower the investment and the running cost the more is the acceptability of the system 
to general people for regular use. 
 This thesis describes development of breath sensors for monitoring exhaled nitric 
oxide and acetone using optical detection. Exhaled nitric oxide is an FDA approved 
marker for monitoring asthma and acetone has applications in monitoring fat oxidation 
and the resulting ketone build up in the blood. The detection based on colorimetric 
changes is effectively realized using a low cost sensing platform. The detection chemistry 
has been supported on inexpensive substrates for lower cost per test. Appropriate 
measures are described to ensure proper online sampling. Real tests were made to show 
the applicability of the developed sensors as tools for use by people in general. 
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2 
BACKGROUND 
2.1 Breath as a clinical sample 
With emergence of advanced analytical techniques exhaled breath is no more just 
a mixture of nitrogen, oxygen, carbon dioxide, and water vapors. Pauling and his 
coworkers, using gas liquid partition chromatography presented in 1971 that breath has a 
complex composition. Even though without identification, he showed existence of 250 
volatile organic compounds in exhaled breath of subjects on a defined diet [14]. Since 
unique smells from breath of patients has been used for diagnosis for a long time, this 
demonstration from Pauling motivated many studies to understand breath compositions 
with a view that components in exhaled breath may have clinically important data which 
was unavailable from routine clinical tests. In the next decade about 200 compounds were 
identified in exhaled breath [43-46]. Several of these compounds have trace 
concentrations in sub ppb and sub ppm levels by volume (Table 2.1). With new and 
improved analytical methods resulting in higher sensitivity and better sampling methods, 
discovery of new components in breath accelerated and now we have a list of more than 
1000 compounds in human breath. These compounds in the breath may result from 
endogenous metabolic processes or may be absorbed as a result of exposure from 
contaminated environment. For this reason exhaled breath has been explored both for 
monitoring metabolic or pathologic process in the body and environmental exposure. 
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Table 2.1: Dynamic range of concentration of some compounds present in exhaled breath 
[47] 
Concentration (v/v) Molecule 
Percentage (%) Oxygen, water, carbon dioxide 
 
parts per million (ppm) 
 
Acetone, carbon monoxide, methane, 
hydrogen 
parts per billion (ppb) Formaldehyde, acetaldehyde, isoprene, 1-
pentane, ethane, other hydrocarbons, nitric 
oxide, carbon disulfide, methanol, carbonyl 
sulfide, methanethiol, ammonia, 
methylamine, dimethyl sulfide 
 
The idea of monitoring physiological processes via breath analysis is based on the 
assumption that there is a gaseous equilibrium between alveolar air and pulmonary blood. 
This means that the exhaled breath gas concentrations are correlated with their respective 
blood concentrations. This direct proportionality between the alveolar concentration CA 
of a VOC and its concentration in the venous blood CB is given by Farhi equation [48, 
49]. 
   
  
        
  ̇
  ̇
  (2.1) 
Here,        is the substance specific blood gas partition coefficient which 
describes the diffusion equilibrium in the respiratory microvasculator,   ̇ is the alveolar 
ventilation which governs the transport of the compound through the respiratory track, 
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and   ̇ is the cardiac output which controls the rate at which the compound delivered to 
the lungs. Considering lung to be a homogenous alveolar unit, end capillary blood 
concentration    , blood inflow/outflow   ̇ and gas inflow/outflow   ̇, mass 
conservation give us the following relationship 
  
   
  
    ̇(     )    ̇(      ) (2.2) 
Here VA is the volume of the pulmonary space for the gas under consideration, 
and CI is its concentration in the inspired air. Considering CI to be negligible and 
assuming steady state condition i.e.               implying no accumulation in the 
lungs and diffusion equilibrium to hold, the relationship becomes 
  ̇     ̇(           ) (2.3) 
which leads to the Farhi equation 
   
  
        
  ̇
  ̇
  (2.4) 
This equation represents a simplified equilibrium description of the gaseous mass 
balance in the lungs. Several experimental and modeling approaches have been presented 
to extend it to chemically bound gases and non-equilibrium processes for it to be 
applicable to a wide range of VOCs [49-53]. 
The diagnostic potential of exhaled breath is huge and has been applied to 
diagnose lung diseases, gastrointestinal diseases, metabolic disorders, renal diseases, liver 
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malfunction and others [4, 54]. Several different classes of compounds result from 
different process in the body.  
Ketone bodies including acetoacetate and β-hydroxybutyrate are produced as a 
result of fatty acid metabolism. Acetone is formed by spontaneous decarboxylation of 
acetoacetate and through dehydrogenation of isopropanol [55]. It is very volatile and can 
be found in breath of all humans [56]. Acetone concentration is reported to increase in 
patients with uncontrolled diabetes mellitus [57-59].  
Saturated hydrocarbons such are ethane and pentane are generated from lipid 
peroxidation of ω3 and ωa6 fatty acids by reactive oxygen species (ROS) [60]. ω3 and 
ωa6 fatty acids are components in cell membranes. Since, reactions of ROS and 
associated lipid peroxidation are the basis for inflammation [61], saturated hydrocarbons 
are found elevated during inflammatory events [62]. Ethane and pentane have been found 
elevated in several lung inflammatory diseases like asthma [63, 64], chronic obstructive 
pulmonary disease [65], pneumonia [66], acute respiratory distress syndrome [67] and 
obstructive sleep apnea [64]. 
Sulfur containing compounds result from incomplete metabolism of methionine in 
the transaminative pathway when mercaptanes are oxidized to sulfides [68]. During liver 
dysfunction, level of sulfur containing compounds like dimethyl sulfide, diethyldisulfides 
and ethyl mercaptane compounds elevate and give characteristic smell to patient’s breath 
[69]. Elevations in sulfur containing compounds have been reported in blood and breath 
of patients with liver cirrhosis [69, 70]. Carbon disulfide seemingly generated as a 
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byproduct of methonine metabolism can act as an exhaled breath biomarker in lung 
transplant recipients with acute allograft rejection [71]. 
Nitric oxide (NO) is a ubiquitous gaseous free radical which plays a role in 
diverse physiological functions [72]. In the endothelium, nitric oxide functions in 
vascular signaling and is responsible for the activity of endothelium derived relaxing 
factor [73]. Released by pulmonary endothelium it mediates inflammatory responses and 
modulates airways smooth muscle contractility, pulmonary perfusion, and immune 
response [74, 75]. NO levels have been found elevated in the exhaled breath of asthmatic 
subjects [76-78]. Elevated NO in exhaled breath of asthma patients has been ascribed to 
constricted airways due to the activation of nitric oxide synthase 2A by damages to 
airway epithelial cells and/or by inflammation [79, 80]. This is helpful in differentiating 
asthma from other non-inflammatory lung disorders [81]. Exhaled NO has been used to 
distinguish healthy subjects with or without respiratory symptoms from patients with 
confirmed asthma [82, 83].Table 2.2 lists selected compounds found in breath, their 
potential origins and potential clinical applications.  
With all the potentials and efforts in the field of breath analysis one would expect 
it to result in several robust procedures to be used as tests of clinical significance. Despite 
all the potential, due to inherent challenges of variability, lack of proper sample 
collection procedures, sample storage and intricate instrumental setups, the progress has 
been slow. Table 2.3 gives a list of tests that have been approved by US FDA for routine 
use in medical practice. 
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Table 2.2: Selected breath components, their potential origin and clinical applications 
Compound Source Potential clinical application 
Acetaldehyde Ethanol metabolism 
Monitoring of ethanol 
metabolism and oxidative 
stress 
Acetone 
Decarboxylation of 
acetoacetate, decarboxylation of 
isopropanol 
Monitoring of diabetes and 
weight loss 
Acetonitrile Uptake of cigarette smoke 
Monitoring of smoking 
behavior 
Ammonia Protein metabolism End stage renal disease 
Dimethyl sulfide Liver failure Monitoring Liver damage 
Ethane Lipid peroxidation product Oxidative stress monitoring 
Ethylene Lipid peroxidation product Oxidative stress monitoring 
Isoprene Cholesterol biosynthesis Statin therapy monitoring 
Malondialdehyde Lipid peroxidation product Oxidative stress monitoring 
Methane Gut bacteria Gastrointestinal diseases 
Propionaldehyde Lipid peroxidation product Oxidative stress monitoring 
Propofol Intravenous anesthetic 
Monitoring of pharmacon 
during anesthesia 
Trimethylamine 
Uptake of trimethylamine or 
precursor 
Monitoring of hemodialysis 
efficacy 
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Table 2.3: US FDA approved breath tests 
Breath Test Application  
Ethanol Screening for blood alcohol  [84] 
Nitric Oxide Monitoring asthma therapy [85] 
Carbon dioxide (CO2) Capnography [86] 
Carbon monoxide (CO) Neonate jaundice, CO poisoning [87, 88] 
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CO2 Halicobactor pylori infection [89] 
Hydrogen Lactose malabsorption [90] 
Alkanes Grade 3 heart allograft rejection [91] 
2.2 Detection techniques for breath analysis 
Though there are numerous gas detection techniques, to detect gaseous 
compounds at trace concentrations among hundreds of other gases and nearly saturated 
humidity with accuracy and precision required for medical diagnosis is challenging. 
Since breath is a complex matrix with components covering a wide dynamic range in 
concentration and diverse physical and chemical properties, numerous techniques have 
been utilized to analyze breath samples. Most important techniques in this field include 
gas chromatography coupled to mass spectrometric detection (GC-MS), selected ion flow 
tube mass spectrometry (SIFT-MS), proton transfer reaction mass spectrometry (PTR-
MS), laser absorption spectroscopic techniques and chemical sensor. Though a detailed 
summary of each technique is beyond the scope of this chapter, a brief overview of few 
techniques used during the course of this thesis work is given in the following 
paragraphs. 
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GC-MS is the most traditional method for detection of trace gases in the breath. 
Many works reporting identities of different VOC’s in breath have used the combination 
of gas chromatographic separation with mass spectrometric detection [3, 92, 93]. In GC, 
complex breath sample is injected into a chromatographic column. As the sample travels 
through the column by the flow of inert gaseous mobile phase, it is separated into 
components. This separation is based on property of the column that interacts with the 
sample. Non polar substrates in the GC column such as silicones separate the components 
according to their boiling points, whereas in a polar column the separation is determined 
by the polarity of the components [93]. This separation leads to different elution times for 
the components from the GC column. For a given analytical condition the elution times 
are compound specific and can be used for identification of the eluting components. 
Coupling of GC with MS analysis adds to its power. The eluting components are fed to 
ionization source leading to fragmentation patterns which are analyzed by a mass 
analyzer. The resulting mass spectra are characteristic of each component and can be 
used to identify the compound when compared to known fragmentation mass spectral 
patterns. Thus, MS provides an extra confirmation step to the previously identified 
compound based on the elution time. For quantification of a compound the GC 
instrument has to be calibrated with standard known concentrations of the pure 
compound. Solid phase microextraction (SPME) is commonly used for sample collection 
followed by automatic thermal desorption into the GC column. This approach, though 
improves the detection sensitivity, it  compromises accuracy because of uncertainties in 
collection and desorption efficiencies. Also, because of the sample collection, feeding 
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and separation steps in the column and pre-concentration, GC-MS is not a real time 
measurement. Despite limitations GC-MS has been used in several earlier and recent 
studies [94-96] and has significantly contributed to our understanding of breath. 
SIFT-MS is a relatively new analytical method to be applied to the field of breath 
research. It has its origins in the selected ion flow tube technique that was developed over 
thirty years ago for studying gas phase ion-neutral reactions occurring in interstellar 
clouds [97, 98]. It is now available as a tool suitable for online monitoring of breath 
samples in real time without the need for sample collection which is a significant 
advantage over GC-MS.  
 
 
SIFT-MS utilizes the fast flow tube technique that allows ion-molecule reactions 
to proceed in a defined time period and facilitates accurate real time quantification of the 
analytes. Figure 2.1 shows a schematic diagram of a SIFT-MS instrument. A mixture of 
positive ions is generated in the microwave discharge ion source from ambient air and 
Figure 2.1: Schematic line diagram of SIFT-MS for analysis of trace gases in air or 
breath samples [1]. 
17 
 
humidity. Precursor ions based on their mass to charge ratio (m/z) are then chosen from 
this mixture using a quadrupole mass filter. Usually either H3O
+
, NO
+
 or O2
+
 is chosen 
because none of them reacts with most common constituents (N2, O2, H2O and CO2) in 
the air but efficiently react with trace VOCs present. The selected ion which is called the 
precursor ion is injected in a flow tube with fast flowing inert carrier gas usually ultra-
high purity helium at a pressure of about 100 Pa. The sample to be analyzed is also 
injected into the flow tube through a calibrated capillary at known flow rate. The 
precursor ions react with the sample to generate product ions. These precursor ions and 
the generated product ions are sampled through a pinhole orifice at the downstream end 
of the flow tube into a differentially pumped quadrupole mass spectrometer and ion 
counting system for analysis.  
SIFT-MS has two modes of operation: 1) The full scan mode allows it to be used 
for detection and quantification of unknown compounds. 2) The multiple ion monitoring 
(MIM) mode for real time quantification of a known analyte in the sample. In full scan 
mode, a full mass spectrum is captured in a specified range of m/z values. The detection 
quadrupole is swept over the range in a chosen time while the sample is introduced into 
the flow tube. The height of each peak and the time is used to calculate the count rates. 
The spectra (Figure 2.2) is interpreted based on the knowledge of the ion chemistry 
involved between sample and the precursor ion. In MIM mode one or more specific 
compounds are chosen to be studied. The downstream quadrupole mass spectrometer is 
rapidly switched between the m/z values of the product ion, precursor ions and their 
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hydrated counterparts. MIM mode generates real time concentration profiles of selected 
compounds and water vapor (Figure 2.3). 
 
Accurate quantification of the compounds requires the reaction times and reaction 
rates to be known. Considering a hypothetical analyte A to be analyzed with H3O
+
 as the 
precursor ion, following reaction would occur 
   
            
Generation of    and loss of    
 depends on the concentration of A in the carrier gas 
[A]. If   is the rate constant for the reaction then the concentration of product ions at time 
t is given by, 
Figure 2.2: A typical SIFT-MS spectrum obtained in full scan mode.  Counts per 
second (c/s) is plotted against m/z of the ions in the selected range of 10-120. 
H3O
+
 has been used as the precursor ion [2].  
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The rate constant is accessible in the software for SIFT-MS analysis through an 
inbuilt library of rate constants. This library has been created and is constantly updated 
based on detailed SIFT studies of the reaction of various classes of compounds including 
alcohols, aldehydes, ketones and hydrocarbons with the three available precursor ions. 
 
Figure 2.3: Time profile of concentrations obtained in MIM mode of SIFT-MS operation. 
Ammonia acetone, water vapors and hydrogen cyanide are simultaneously analyzed over 
three exhalations of breath. 
 With MIM mode and fast response time, SIFT-MS has been used for numerous 
breath sample studies. Subjects can directly breathe into the setup through a mouthpiece. 
To avoid condensation of humidity and blocking of the capillary, the sampling line is 
heated to about 100
O
C. During the course of this thesis work, SIFT-MS has been used as 
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a standard detection method for acetone and water vapors in direct and conditioned 
breath samples.  
Spectroscopic, including fluorescence and chemiluminescence based 
measurements are used for detection and quantification of specific compounds of interest 
in the breath. These methods are more suitable for studies involving already established 
breath markers or for monitoring identified and promising compounds. Nitric oxide is 
one such molecule which has been accepted as a marker for therapeutic monitoring of 
inflammation in asthma. During the work presented in chapter 3 on development of 
breath nitric oxide sensor, chemiluminescence based nitric oxide (NO) monitor has been 
used as the standard detection instrument. The detection is based on reaction of nitric 
oxide with ozone (O3). This reaction results into production of nitrogen dioxide in the 
excited state.  
         
     
   
         
  At reduced pressure, the excited nitrogen dioxide molecules emit radiations at 
wavelengths longer than 600 nm in red to near-infrared region of the spectrum [99]. 
These radiations are detected by a thermoelectrically cooled, red-sensitive 
photomultiplier tube. Since the ozone is generated in the instrument at a concentration of 
about 2% by volume, concentration of NO up to 500 ppmV can be measured. The 
detection limit for gas phase NO is about 0.5 ppbV. The advantage of these methods is 
that the detection is very specific, operation of the instrument and interpretation of the 
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data is relatively simple when compared to GC-MS or SIFT-MS. Spectroscopic methods 
have been employed to detect several compounds in breath including hydrogen peroxide 
[100], nitric oxide [101], carbon dioxide[102], acetylene [103], hydrogen sulfide [104] 
and acetone [105]. 
2.3 Portable device: 
 Though several studies related to breath biomarkers and their relevance to specific 
disease conditions have been reported, many analytical tools have been used to detect 
these biomarkers in exhaled breath, numerous potential sensor methods have been 
published, but still, portable breath sensor devices intended for en mass use are not 
available. 
 A portable breath sensor is warranted in modern health care where regular 
monitoring results in reduction of the ever growing burden of health care costs. Regular 
monitoring is not only necessary for managing clinical conditions as is done by blood 
glucose monitoring in case of diabetes but can also give early indication of the impending 
danger.  However, regular monitoring is not so easy especially in free living conditions 
because of lack of easy to use devices, high cost per test and noncompliance from the 
users. It is best possible when the monitoring procedure is simple and painless, the cost 
per test is affordable, the data generated is processed, logged and can be analyzed with 
ease to track the user’s personal record with minimal effort on the user’s part to increase 
compliance. Breath analysis, of course, presents an easy to use and painless approach but 
still, affordable devices and low cost tests are not available. 
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Developing a solution to this effect requires a comprehensive approach where 
attention is paid not only to the detection technique but equal importance is given to 
every other component of the test like sample conditioning and delivery, individual 
variability, cost effective hardware, and smart compact device design. During the work 
presented in this thesis, sensors for exhaled nitric oxide and acetone have been 
developed. These gases are elevated in patients with asthma and diabetes respectively. 
Asthma and diabetes are among the top chronic conditions leading to hospitalization in 
US through emergency department [106]. 
Colorimetry has been chosen as the detection principle. Colorimetry is attractive 
because it results from strong specific interactions between molecules like formation of 
bonds, acid base interactions or charge transfer and π-π molecular complex formation. 
These strong interactions provide much needed specificity to detection towards a target 
molecule in the complex breath matrix consisting of thousands of interfering molecules in 
a wide concentration range. Many sensor approaches referred to as electronic noses have 
relied on van der Waal’s interactions and physical adsorption which are much less 
specific. The detection is usually helped by use of pattern recognition algorithms on data 
generated by an array of surfaces available for interaction [107]. When these sensors are 
exposed to complex samples, especially moist samples like exhaled breath, the data 
interpretation can be difficult and complicated. So these sensors are at best qualitative 
and can be used for classification based on training through the data. Colorimetry is also 
attractive because given sufficient sensitivity of the color change, it allows for the use of 
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very cost effective and compact detection hardware like a digital camera or photodiodes 
supported by suitable data relay circuit for real time read out of the signal.  
To truly achieve an affordable sensing solution, not only a cost effective hardware 
is required but low cost per test is also needed. For example commonly available blood 
ketone measurement devices based on electrochemical sensing principle cost around $15 
may sound reasonable in US but they still need a measurement strip which costs around 
$7 for each test. If a patient needs to monitor her/his blood ketone levels regularly on a 
daily basis or multiple times a day then the costs will mount up and the measurement is 
no longer easily affordable. This would mean that the most frequently replaced 
component does become a limiting factor for the use of the device. Keeping this in mind, 
replaceable sensor cartridge which houses the color changing chemicals for the 
developed colorimetric sensors have been carefully optimized on very low cost cellulose 
paper coated with nanoporous alumina or silica for increased sensitivity. The hardware 
for sample delivery has been kept minimal by either using miniature pumps in case of the 
nitric oxide sensor or without the pump in case of the acetone sensor. For sample 
conditioning of the humid sample, optimized amounts of calcium chloride after numerical 
simulation of desiccation process have been used. The overall aim has been to develop 
and integrate approaches that focus on functioning of the device in real scenario with 
minimal cost and effort to the user.  
Wireless data transmission capabilities, processing and presentation of the data on 
smartphone devices and compact housing for the hardware have been developed by other 
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members of the lab at the Center for Bioelectronics and Biosensors at the Biodesign 
Institute, ASU.  
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3 
SENSOR FOR EXHALED NITRIC OXIDE 
3.1 Introduction 
Exhaled human breath consists of several gases including nitric oxide (NO) in 
ppbV range [108].  Endogenously, nitric oxide is generated by three isoenzymes of NO 
synthase (NOS). Isoforms I (NOS1) and 3 (NOS3) are constitutive forms and play 
regulatory roles such as neurotransmission and regulation of local blood flow. Isoform 2 
(NOS2) which is the inducible form of NOS, is not constitutively expressed but is 
induced by stimuli resulting from inflammation and infections. The large amount of NO 
produced by NOS2 may have proinflammatory effect. In case of inflammatory airway 
diseases such as asthma, exhaled nitric oxide has been found to increase mainly because 
of inducible NOS2.  
Asthma is a chronic respiratory disease that affects 235 million people worldwide 
including 18.9 million adults and 7 million children in United States alone [109-111]. 
According to the National Asthma Education and Prevention Program Expert Panel [112] 
from the US National Institutes of Health, “Asthma is a common chronic disorder of the 
airways that is complex and characterized by variable and recurring symptoms, airflow 
obstruction, bronchial hyper responsiveness, and an underlying inflammation. The 
interaction of these features of asthma determines the clinical manifestations and severity 
of asthma and the response to treatment.” Because of the complexity of asthma, the 
pathogenic mechanisms leading to the condition may be several. In addition, patient’s 
response to different therapies is not uniform, nor is it necessarily consistent in individual 
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patients over time. Though the underlying causes and the responses to therapies may 
vary, the vast majority of these worsening are associated with increased levels of airway 
inflammation. Consequently, analytical measurement of airway inflammation in asthma 
could be of significant importance. Such measurements could inform the proper choice of 
therapy and help to avoid medication overdoses. The most direct measures of airway 
inflammation, however, are too invasive and have limited clinical use. Bronchial biopsy 
which is considered to be the gold standard of assessing airway inflammation is 
expensive, invasive and technically complex. 
The level of exhaled nitric oxide (eNO) in asthmatic patients is elevated [78, 113]. 
This elevation is associated with increased expression of inducible NOS2 which is 
sensitive to corticosteroids [80, 114-116]. Further studies show exhaled nitric oxide’s 
association with allergen induced airway inflammation [117-119]. eNO also correlates 
well with inflammatory markers in bronchial biopsy, broncho-alveolar lavage and 
induced sputum analysis [117, 120-122]. These studies have established eNO as a 
standardized noninvasive biomarker that evaluates airway inflammation in asthma [77, 
123-125]. Its utility to assess response to anti-inflammatory therapy has also been well 
studied [126, 127]. 
Since the detection of NO in exhaled breath in 1991 by chemiluminescence, 
diazotization and mass spectrometry [108], efforts were made to develop sensitive and 
simpler nitric oxide analyzers. The most commonly used gold standard method is based 
on chemiluminescence which has been commercialized for breath analysis. For example 
NOA280i (Severs, GE Analytical Instruments, Boulder, USA), Analyzer CLD 88sp 
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(ECO MEDICS, Duernten, Switzerland) and NA623N (Chest, MI, Tokyo, Japan). 
NOA280i has been used as the reference standard method for NO detection in the work 
presented in this chapter. The instrument can be used for both online and offline 
measurement of exhaled nitric oxide. Measurement of eNO is critically dependent on 
expiratory flow rate [128, 129]. Also, NO levels in dead space air and nasal cavity are 
high [130, 131].  Therefore, a standardized method to sample eNO is needed. Such 
standardized methods have been recommended by international guidelines for sampling 
and measuring eNO both in adults and children [132-135]. 
Considering the value of monitoring eNO for personalized asthma management, 
low cost and portable solutions would better serve patients and clinicians. For this, 
several platforms have been explored. Commercial systems based on electrochemical 
detection which are more compact and portable than the chemiluminescence method are 
available. For example, NIOX MINO (Aerocrine, Stockholm, Sweden) and NObreath 
(Bedfont Scientific, Kent, UK). These sensors still cost a few thousand dollars. Also, they 
suffer from non-uniform calibration issues and show deviations in correlation [136, 137]. 
Despite these issues they still present a step forward towards a solution for clinicians. The 
sensor presented in this chapter aims to reach the goals of being a portable, low cost and 
easy to use device which can be afforded and  used not only by clinicians but also by 
patients to manage their conditions at a personal level.    
3.2 Detection principle and setup 
The detection principle used to detect nitric oxide was based on colorimetric 
change of chemical probe on exposure to nitrogen dioxide [138]. Exhaled breath sample 
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was conditioned through an oxidation tube which provided the only source of nitrogen 
dioxide for reaction with the probe. Figure 3.1 shows visible spectrophotometric changes 
of the molecular probe, o-phenylenediamine upon reaction with nitrogen dioxide. 
Increase of absorbance in the range of 350-550 nm observed in the figure formed the 
basis of the sensing mechanism. 
 
Figure 3.1: UV-visible spectrum of o-phenylenediamine upon reaction with 10 ppmV 
NO2  
For detection of the color development, a sensing platform was developed which 
consisted of a complementary semiconductor metal oxide (CMOS) imager as optical 
detector which was controlled by a software program developed in the Center for 
Bioelectronics and Biosensors at the Biodesign Institute. The imager captured real time 
intensity at an acquisition rate of 5 Hz from two different elements. One of the element 
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acted as a sensor and the other as a reference (Figure 3.2). The reference was devoid of 
the colorimetric probe. So, upon exposure to the sample it did not result in color change 
but correlated with intensity changes due to other factors including scattering, changes in 
the light source or noise in the detection circuit. This allowed for correction of these 
factors in the signal from the sensing region. The logarithmic ratio between the sensing 
and the reference elements was evaluated as the output signal. This signal corresponded 
to absorbance change due to the reaction and was directly proportional to the 
concentration of the analyte, nitric oxide in this case. 
                 (
        ( )
          ( )
)           (i) 
 
Figure 3.2: Schematic representation of the NO sensing platform. 
 30 
 
Figure 3.3 (A) shows the intensity value captured by the imager from the two 
elements. Both the regions were purged with clean air for the first minute. In this duration 
the intensity was nearly constant with slight drift due to flow on both the elements. For 
the next two minutes nitrogen dioxide was sampled which resulted in a linear decrease in 
the intensity on the sensing element due to color development. The reference element was 
not affected by the introduction of the sample. The system was again purged for the next 
minute. In this duration the color development stopped and both sensing and reference 
elements went back to a constant intensity with flow drift.  
The intensity data was transformed to change in absorbance as shown in Figure 
3.3(B) using equation (1). The absorbance change increased linearly with time. The 
sensitivity of detection could be optimized by adjusting the sample injection time.  
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Figure 3.3: (A) Transmitted intensity of light recorded by the optical imager from the 
reference and sensing elements during NO2 measurement. The injection of 50 ppbV NO2 
sample was preceded and followed by air purging for baseline collection. (B) The 
observed intensity data converted to change in absorbance (-log (sensing 
intensity/reference intensity) - constant). This signal was proportional to concentration of 
NO2 in the sample. 
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The developed detection setup was simple and compact allowing for a low cost 
and portable device (Figure 3.4). The sensor material was low cost and highly sensitive 
due to the support matrix. The support matrix provided (1) an excellent host for high 
surface concentration of the molecular probes, enabling a high dynamic detection range 
and lifetime, (2) a good medium for quick diffusion and transport of nitrogen dioxide, (3) 
a medium that promoted the formation of colored products and (4) a highly stable support 
for the sensor for several months. 
 
 
Figure 3.4: Sensor prototype implemented with white LED as the light source and a 2 
megapixel web camera as the imager. 
3.3 Experimental 
3.3.1 Standard gas samples  
All optimizations were performed with standard nitrogen dioxide (50 ppmV in 
nitrogen) and standard nitric oxide (50 ppmV in nitrogen) gases from Praxair Inc. The 
testing concentrations of these gases were prepared in tedlar bags (Custom Sensor 
Solutions Inc.) by dilution with humidified air (Ultra Zero; Air Liquide). The 
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concentration of the prepared bags were measured by a reference chemiluminescence 
detector. 
3.3.2 Collection of breath samples 
Breath samples were collected in tedlar bags by blowing into the bag through a 
barometric valve against a constant pressure of 12 cm water at room temperature. Before 
blowing into the bags, the inhalation was done through a particle filter and initial 150-200 
mL of the sample was discarded. 
3.3.3 Reaction product characterization 
High Performance Liquid Chromatography/Mass Spectrometry (HPLC-MS) was 
used to characterize the reaction products. Two sensing elements (Control A and Sensing 
element B) were treated according to the following protocol:  
Control A: A sensing membrane prepared with o-phenylenediamine was dipped in 2 mL 
of acetonitrile (HPLC grade) and was shaken for 5 min. After this, the liquid extract was 
centrifuged and the supernatant was injected into a HPLC for separation and collection of 
the separation products. The main product fraction was analyzed by MALDI-TOF mass 
spectrometer. 
Sensing element B: A sensing membrane prepared with o-phenylenediamine was used to 
test a high NO2 concentration (1 ppmV) for a long period of time until a clear color 
development was visually observed. Then, the sensing element was dipped in 2 mL of 
acetonitrile (HPLC grade) and mildly shaken for 5 min. The liquid extract was 
centrifuged and the supernatant was injected into a HPLC. The separated products were 
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collected, and the main product fraction was analyzed by MALDI-TOF mass 
spectrometer. 
3.4 Results 
3.4.1 Sensor response 
The sensor showed a linear time response to nitric oxide injection as shown in 
Figure 3.5. Nitric oxide sample at a concentration of 50 ppbV was injected for 20 s after 
30 s of purging with humidified air. The system was again purged for 20 s following 
sample injection. The setup had a low baseline noise level of 5x10
-5
 absorbance units. At 
this noise level, the detection limit of 0.4 ppbV was achieved. The advantage of this 
sensitive response was that the time of detection could be as low as 5 s for detection in 
clinically relevant range of NO concentration. 
 
Figure 3.5: Sensor response to 50 ppbV NO. 
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3.4.2 Sensor optimization 
The molar extinction coefficient of the reaction product was estimated by fitting 
the peak absorbance data (Figure 3.6) obtained by reacting 1 mM o-phenylenediamine 
solution with nitrogen dioxide on a pseudo first order kinetic model.  
   (      ) (1) 
  
 
  
                  (2) 
Here, A was the absorbance, α and β were fitting parameters, ε was the molar extinction 
coefficient and C0 was the initial concentration of o-phenylenediamine. The calculated 
molar extinction coefficient of 1.5x10
2
 M
-1
.cm
-1
 was about an order of magnitude lower 
compared to other regular colorimetric dyes. Thus, the sensor had to be optimized for 
maximum capture of the analyte gas. Alumina coating was used for this purpose with 
provided an increased surface area improving the sensitivity of detection by a factor of 
2.5 as shown in Figure 3.7. The capture efficiency of the gas was estimated to be 93% by 
measuring the concentration of the inlet and outlet sample and taking the ratio of gas 
consumed to the amount of gas introduced. 
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Figure 3.6: Peak absorbance data collected over time with gaseous NO2 reacting with 
1mM o-phenylenediamine. The data is fitter on pseudo liner kinetic model A = α (1-e-βt). 
 
Figure 3.7: Detection of 50 ppbV NO with cellulose sensing element without alumina 
treatment and after alumina treatment. The signal improved by a factor of 2.5 after 
alumina treatment of the cellulose membranes. 
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The sensors were tested for reproducibility of detection for a single injection and 
also over multiple injections on the same sensor. Figure 3.8 shows 16 consecutive 
injections of 35 ppbV NO separated by a short purging time with a variation of 7%. 
Figure 3.9 shows response of 29 different sensors towards 50 ppbV NO. The mean 
detected concentration was 50.43 ppbV with a variation of 6.5%. 
 
Figure 3.8: Change in absorbance measured over 16 consecutive injections of 35 ppbV 
NO on a signal sensing element. Injections were separated by a short purge time. The 
coefficient of variation was 7%. 
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Figure 3.9: Detection of 50 ppbV NO on 29 different sensors. The mean detected 
concentration was 50.43 ppbV and coefficient of variation was 6.5%. 
3.4.3 Mass transport study 
The response of the sensor was characterized as a function of sample flow rate. 
The flow was restricted to values achievable with a miniature pump used in the portable 
device. A linear dependence of the response on the flow rate was found as shown in 
Figure 3.10 indicating mass transport controlled response of the sensor. To maximize the 
sensitivity a flow rate of 450 ml.min
-1
 was used in this work. 
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Figure 3.10: Response of the sensor to 200 ppbV NO2 at different sample flow rates 
achieved using miniature pumps. Injection time was 20 s. 
 
3.4.4 Sensor calibration and correlation 
The sensor was calibrated in the clinically relevant range of 5-200 ppbV NO 
using standard gas. The response to NO concentration was linear as shown in Figure 3.11 
with a correlation coefficient of 0.996 and slope 4.9x10
-5
. The error bars represented the 
standard deviation of six measurements for each concentration. 
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Figure 3.11: Sensor calibration curve. Standard NO gas was used and reference 
measurements were done with chemiluminescence based NO analyzer. 
NO concentration in breath samples were measured offline after collection of the 
samples in tedlar bags according to the guideline provided by ATS. Figure 3.12 shows a 
correlation plot of the measurements done with the developed sensor versus the 
concentrations measured with the gold standard chemiluminescence method. The breath 
samples were collected and then the same sample bag was tested with the 
chemiluminescence method followed by the developed sensor. The slope of the 
correlation plot was 0.9. 
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Figure 3.12: Correlation of the developed colorimetric sensor with the gold standard 
chemiluminescence detection. Slope was 0.9. 
3.4.5 Selectivity of detection 
The selectivity of the sensor was evaluated by measuring its response towards 
several compounds commonly found in human breath and the environment. Given the 
low response of the molecular probe to these interfering gases, tests for selectivity were 
carried out at much higher concentration of the interfering gases than regularly found in 
human breath or the environment. The selectivity coefficient was calculated as the ratio 
of sensor response to nitric oxide and to the interfering gas at the same concentration. 
Table 3.1 lists the selectivity coefficient for several interfering gases. There was no 
significant effect on the signal of these gases at their commonly found concentrations in 
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the breath. However, the sensor showed a selectivity coefficient of 0.9 towards ozone 
which is an environmental pollutant. Considering that human breath is devoid of ozone 
and the sensor sampling time to be small, the possible effect of environmental ozone was 
not an interference concern. Though, in order to use the sensor for environmental 
monitoring, ozone scrubber based on molybdenum oxide derivative (2B Technologies, 
Bouler, CO) was successfully integrated to remove ozone from the sampling line [139]. 
Table 3.1: Selectivity of the NO2 test with o-phenylenediamne over possible interfering 
gases. 
Compound Selectivity coefficient 
SO2 6.1 x 10
4
 
CO 3.1 x 10
5
 
CO2 1.5 x 10
7
 
NH3 1.3 x 10
4
 
H2S 1.7 x 10
4
 
Acetone 4.5 x 10
4
 
Ethanol 5.6 x 10
4
 
Ozone 0.9 
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3.4.6 Sensor stability 
A batch of several sensing elements was prepared and stored at ambient 
temperature in a clean nitrogen atmosphere to test their stability. After different periods 
of time, a sensor was taken out from the storage and tested against 50 ppbV of standard 
NO2 sample. The response of the sensor was tested for a period of 4 months with a 
variation of 10% as shown in Figure 3.13. 
 
Figure 3.13: Response of different sensing elements prepared in one batch and stored at 
room temperature in a nitrogen atmosphere. Tests were performed with 50 ppbV NO2 
samples. 
3.4.7 Reaction product characterization 
Figure 3.14 shows the mass spectrum obtained from the HPLC separated 
component from the reference control and sensing elements. It was clear that the main 
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compound in control (before the reaction with NO2) corresponded to o-phenylenediamine 
with a molecular weight of 108 a.m.u, and that the main product after the reaction in 
sensing element had a molecular weight of 211 a.m.u. 
 
Figure 3.14: Mass spectra from MALDI-TOF analysis of HPLC separated component 
corresponding to the main product in control (Red) and sensing (Blue) elements before 
and after the reaction with 1 ppmV NO2. 
3.5 Conclusions 
In summary, a working sensor prototype for the measurement of eNO based on 
oxidation of NO to NO2 followed by colorimetric reaction and detection has been 
developed. All components of the chemical sensor, detection setup and sample delivery 
have been carefully optimized to achieve ulrasensitive detection. The measurement of 
nitric oxide concentrations in the clinically relevant concentration range with high 
sensitivity, precision and quick response time has been demonstrated. The instrument has 
advantages of being portable, cost effective and simple in operation compared to 
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currently used eNO detectors. The instrument holds promise for giving the clinicians and 
patients an affordable tool for better management of asthma. 
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4 
ONLINE SAMPLE CONDITIONING FOR PORTABLE BREATH ANALYZERS 
4.1 Introduction 
To be relevant as a solution, a sensor has to be capable of working in the real 
world. For this, all process till the end detection need to be efficiently working. Even 
though several sensor publications present new chemical detection methodologies sample 
collection and conditioning that often determine whether a sensor can work in real world, 
are much less emphasized. This is especially the case for breath analyzers where sample 
conditioning presents a significant challenge. It is even more difficult in a portable breath 
analyzer with limited hardware and size constrains. Human breath is nearly saturated 
with water vapor (>95% RH) [140, 141] which coming out at body temperature 
condenses in the sensor. This causes several problems including blockage of sampling 
lines, pre-concentration of unwanted analytes and noise due to unpredictable changes in 
detection properties like mass, conductivity or optical transmission and often leads to the 
failure of the breath analyzer. For proper functioning a breath analyzer requires proper 
sample conditioning before detection [101, 142].  
A solution commonly employed to condition high humidity in the breath sample 
is introduction of nafion tubing in the sampling line to reduce humidity. However, the 
reported efficiencies of humidity reduction by nafion tubing are highly variable, ranging 
from 58% to 98% depending on ambient humidity [143, 144]. For this reason many 
applications must flow additional drying gas into the nafion tubing in order to maintain 
the efficiency [145], which adds complexity into the device, and also makes it unsuitable 
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for a portable breath analyzer for personal monitoring. A more serious issue with the 
nafion approach is that it removes not only unwanted humidity, but also partially or 
completely (75% to >90%) remove many wanted analytes, such as low-molecular-
weight, polar, oxygenated compounds, including some ketones, alcohols, aldehydes, and 
water-soluble ethers [143]. These analytes are of high clinical significance for different 
diseases. Real time breath sample measurement without removal of humidity has been 
done using mass spectrometric platforms including selected ion flow tube (SIFT) [146, 
147] and proton transfer reaction (PTR) [50, 148, 149] mass spectrometry. These 
techniques employ special handling of breath sample to avoid humidity condensation and 
require long heated tubes and capillaries heated up to 100 
o
C [51, 150, 151]. In addition 
to conditioning the humidity of a breath sample, another critical requirement for breath 
analyzer is to provide an appropriate volumetric flow rate and back pressure. The flow 
rate and back pressure requirements differ depending on specific guidelines for the 
analyte being measured. For example, in the case of breath nitric oxide, a biomarker for 
inflammation, the American Thoracic Society, recommends that the back pressure should 
be at least 5 cm H2O [152].  
This chapter outlines an effort to overcome the difficulties discussed above. The 
results have been published in scientific journal [153] where a breath sample conditioning 
approach is presented which is based on desiccant particles packed in tubing. The tubing 
can be integrated into the inlet of existing breath monitoring devices. The relationships of 
the output humidity, flow rate and pressure in terms of controllable parameters, such as 
particle size and tubing geometry is developed. The relationships are established based on 
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numerical simulation and validated experimentally. Using this approach, mouthpieces 
have been designed and used for nitric oxide detection using a hand held device 
developed during the work presented in chapter 3 [138].  
4.2 Experimental and Simulation Methods 
4.2.1 Simulation methods 
Numerical simulation of the desiccation process in the mouthpiece was performed 
using finite element method software COMSOL multiphysics 3.5. The simulation 
included models for flow and mass transport in the porous medium of calcium chloride, 
which was used as a desiccant material to adsorb water and control humidity. 
Temperature change during the desiccation process was not taken into account for 
simplifying the model. It was experimentally observed that the temperature increased by 
about 20 
o
C at the mouthpiece inlet for 1 L of breath sample whereas the outlet 
temperatures increased by 1-2 
o
C. This rise in temperate did not have considerable effect 
on the working efficiency of the overall desiccant tube (Table 2) since enough material in 
the tube was far away from saturation. A 2-dimensional rectangular geometry with 
rotational symmetry, as shown in Figure 4.1, was used to simulate the cylindrical tubing. 
The tubing, defined as a subdomain, was packed with the desiccant particles of different 
diameters (d) into a porous structure, with porosity, εp, varying from 0.25 to 0.65. The 
permeability (κ) of the system for a given porosity and particle size was estimated by 
Kozeny’s relation [154], 
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Figure 4.1: Representation of the modeling domain of the cylindrical desiccation tube in 
two dimensions assuming a rotational symmetry of packing. 
            
    
 
(    )
   (4.1) 
The constant in the equation was determined experimentally to be 984 by 
measuring the sample flow rate (v) and pressure difference across a known length (Δx) of 
the mouthpiece using Darcy’s law [155], 
  
 
 
  
  
 , (4.2) 
where η is the dynamic viscosity (1.74x10-5 Pa.s) of humid air at physiological 
temperature [156]. 
Brinkman equations given by 
 
  
  
  
    [ 
 
  
(   (  ) )    ]    
 
 
  (4.3), 
      (4.4) 
were used to model the flow of breath through this medium, where, ρ denotes the density 
of humid air (1.15 Kg.m
-3
) and, u represents the velocity, and   refers to the pressure. 
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Equation 4 above implies that the fluid flow is incompressible in the subdomain. Since 
Mach number for the flow at 6.67 L.min
-1
 through a typical mouthpiece geometry is less 
than 0.3, the only appreciable fluid density change resulted from change in temperature 
of the breath due to rise in desiccant temperature. The increase in breath temperature was 
measured to be less than 3 
o
C resulting in ~1% increase in density for which the 
assumption of incompressible flow is valid. Boundary conditions for the flow were set as 
follows, 
Boundary 1:        (inlet), where u0 is the linear flow velocity at the inlet; 
Boundary 2 and Boundary 3:     (wall); 
Boundary 4:   = 0 (outlet). 
With these subdomain and boundary settings, the velocity field was determined and the 
solution obtained was further used to solve the mass transport process using COMSOL 
3.5. 
Mass transport of water within the desiccant tube was described by the diffusion-
convection equations, 
   
  
   (          )    , (4.5) 
where Ci denotes the concentration of the species, D is the diffusion coefficient, u 
represents the velocity and R refers to the rate of consumption of species i. These 
equations were applied to the two components of the desiccation process viz. humidity in 
the breath (i=1) and the surface binding sites available on desiccant calcium chloride for 
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capture of humidity (i=2). For breath, the diffusion coefficient of water vapor was set to 
be 4.6x10
-7
 m
2
.s
-1
 [157]. The boundary conditions were set as follows, 
Boundary 1:      
  (    
 
 ) (inlet, allows humidity to rise from 0 to within 1% of 
the maximum breath humidity    
   in 10 s compensating for time lag due to sampling of 
non-alveolar dead space air), 
Boundary 2 and Boundary 3: n   (D C1 + C1u) = 0 (wall), and 
Boundary 4: n   (D C1) = 0 (outlet, no convective flux). 
For binding sites on the solid calcium chloride, diffusion was neglected and all the 
boundaries were set as wall for mass transfer [i.e. n   (D C2 + C2u) = 0] assuming no 
inflow or outflow of the desiccant material through any boundary. The rate of water 
vapor consumption was given by the linear driving force approximation [158-160], 
     ( 
    ), (7) 
where, k0 is mass transfer coefficient, obtained from parameter fitting to be 5.5x10
-3
 s
-1
, 
Cs represents the surface concentration of water on the calcium chloride surface at any 
given time and C* is its equilibrium value. Equilibrium water concentration was modeled 
through Dubinin-Astakhov equation approximated as [161-163], 
   
  
     
      
 , (8) 
where,   
  represented the initial concentration of binding sites on calcium chloride 
available for humidity capture. k1 and k2 were equilibrium parameters obtained from 
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fitting, which were 0.33 m
3
.mole
-1
 and 0.01 m
3
.mole
-1
, respectively. The surface humidity 
concentration at any time was represented as, 
     
      . (9) 
Finally the rate of consumption was obtained as 
    [ 
  
      
      
 (  
     )] . (10) 
These mass balance equations with the appropriate boundary conditions described above 
were solved using COMSOL 3.5 coupled with the velocity field obtained earlier with the 
flow simulation to generate concentration profile of breath humidity introduced into the 
desiccation tube.  
4.2.2 Experimental validation of mouthpiece performance 
In order to experimentally validate the simulation results, several mouthpieces 
were prepared by packing desiccant particles into cylindrical tubes.  Different particle 
sizes of the desiccant were obtained by refining anhydrous calcium chloride pellets 
(Fisher Scientific, 4-20 mesh). These refined particles were size selected by sieving 
through wire meshes of predefined sizes. Average particle sizes of 1.15 mm and 0.65 mm 
were chosen for use. Cylindrical plastic mouthpiece (VacuMed, Part# 1018-22) with 
internal diameter of 22mm was used for packing these particles at porosity values of 
0.425 and 0.365 respectively. Mouthpieces with three different lengths (12 mm, 24 mm, 
and 46 mm) were tested.  
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Humidity levels of the breath sample before and after passing through the 
mouthpiece were measured using a selected ion flow tube mass spectrometer (SIFT-MS) 
(Instrument science Ltd.) operating in multiple ion monitoring mode with H3O
+
 as the 
precursor ion [146]. The backpressure generated by the mouthpiece was measured using 
a pressure sensor (Freescale, Part# MP3V5004G) at a fixed sample flow rate. Sample 
flow rate from pressurized gas container (Praxair, Breathing grade air) was controlled 
with pressure regulators and monitored with a mass flow meter (Sensirion, EM1).  
4.2.3 Integration of the mouthpiece with breath analyzers  
The mouthpiece and a non-rebreathing T-valves (VacuMed, Part# 1464) were 
integrated into a portable breath nitric oxide sensor developed in our lab. The breath 
sensor was based on selective colorimetric change due to redox chemistry of 
phenylenediamine derivatives with the analyte [138]. Subjects blew directly into the 
mouthpiece for online measurement. The readings from the portable nitric oxide sensor 
were compared and correlated with chemiluminescence detection (Sievers NOA), which 
is the gold standard for nitric oxide measurement. Selective capture of humidity over 
some other gases by the desiccant material was tested with samples collected offline in 
metal laminated tedlar bags at a flow rate of 6.7 L.min
-1
 using commercial sensors. 
Acetone and ammonia were measured with SIFT-MS, carbon dioxide was measured 
using absorption infrared based hand held monitor (Telaire® 7000 Series) and oxygen 
was measured using a portable electrochemical sensor (Vascular technologies). 
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4.3 Results and discussions 
4.3.1 Simulation 
Flow and mass transfer simulations were carried for several mouthpiece 
configurations. Figure 4.2(A) shows the flow profile obtained from a 30mm long 
desiccant tube, 15mm in diameter, packed with calcium chloride particles of 1.15 mm 
average diameter with a porosity of 0.425. For this porosity and particle size at a flow 
rate of 6.67 L.min
-1
, the velocity field is homogenous due to porous properties of the 
structure, which is in contrast to parabolic velocity fields generally obtained under similar 
conditions in a non-porous free channel. Figure 4.2(B) shows the simulated pressure 
profile along the tube. The pressure drop increases with the increasing length of the 
packing material at a given packing density. Values for back pressure resulting from 
different particle sizes and porosities of packing for a given amount (5 g) of calcium 
chloride were also calculated as shown in Table 4.1. 
 
Figure 4.2: (A) Simulated velocity field along the tube shows uniform flow field 
established at a given flow rate of 6.67 L.min
-1
, particle size of 1.15 mm and porosity of 
0.425. (B) Simulated pressure profile along the tube showing increasing back pressure 
with tube length assuming uniform packing density. 
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Table 4.1: Simulated values of back pressure in cm H2O generated in the desiccant 
mouthpiece for varying porosities and particle sizes. Simulation is for 5 grams of calcium 
chloride. 
Particle size 
Porosity 
0.25 0.35 0.45 0.55 0.65 
0.35 mm 243.50 66.68 22.46 8.23 3.01 
0.70 mm 60.91 16.67 5.61 2.05 0.75 
1.05 mm 27.07 7.41 2.49 0.91 0.33 
1.40 mm 15.22 4.17 1.40 0.52 0.18 
 
The data from table 1 provides guideline on packing of the desiccant material to 
achieve the desired back pressure range by changing either or both the particle size and 
the porosity of the mouthpiece. It is evident that back pressure at a given flow rate can be 
reduced by either increasing the particle size or the porosity of packing for a given mass 
of desiccant and mouthpiece geometry. Simulations were also carried out to obtain the 
effect of mouthpiece geometry (diameter and length) for a fixed particle size and porosity 
of packing assuming uniform packing density. Figure 4.3 plots pressure drop as a 
function of tube geometry with particles 1.15 mm in diameter packed with a porosity of 
0.425. It is evident from the plot that the pressure drop decreases with increasing 
diameter and decreasing length of the mouthpiece for a given volumetric sample flow 
rate.  
While providing an appropriate backpressure with the mouthpiece is an important 
requirement for many breath analyzers, other important parameters include the 
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desiccation efficiency, which should be considered together with the backpressure. For 
this reason the desiccation process was simulated. The desiccation of the breath along the 
tube (15 mm diameter, 30 mm length, 5 g calcium chloride, 1.15 mm particle diameter, 
porosity 0.425) is shown in Figure 4.4. Humidity of the sample decreases along the tube 
resulting in dryer output of the sample. Humidity levels at boundary 1 (inlet) and 
boundary 4 (outlet) were integrated for 30s in order to calculate of the efficiency 
(output/input %) of the desiccation process. 
 
Figure 4.3: Pressure drop as a function of tube geometry for a given volumetric flow rate 
(6.67 L.min
-1
). 
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Figure 4.4: Simulation result of breath humidity concentration along the desiccation tube. 
Result is for a volumetric flow rate of 6.67 L.min
-1
 and sampling time of 30 s through a 
desiccant tube (15 mm diameter, 30 mm length, 5 g calcium chloride, 1.15 mm particle 
diameter, porosity 0.425). 
Desiccation efficiencies with different particle sizes of the desiccant particles 
were simulated for a given flow and amount of desiccant. Figure 4.5 shows the 
desiccation efficiency decreasing with increasing particle size for 5 g of calcium chloride. 
The efficiency was found to be independent of the packing porosity under these 
conditions. Desiccation efficiencies were also simulated for a fixed particle size and 
packing porosity with changing mouthpiece geometry (length and diameter). Figure 4.6 
shows a plot of desiccation efficiency as a function of mouthpiece geometry with 1.15 
mm wide particles packed with a porosity of 0.425. It can be seen from the plot that the 
efficiency of desiccation improves with increasing length and diameter (i.e., volume) of 
the mouthpiece.  
These simulation results are useful in choosing the best parameters for preparing a 
customized mouthpiece for any breath analyzers. These parameters include mouthpiece 
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geometry (length and diameter), particle size and packing porosity. It is also clear that if 
any of these parameters are constrained based on particular needs of certain device then 
other parameters can be varied to achieve the desired performance. 
 
Figure 4.5: Desiccation efficiency for different particle sizes at a fixed geometry of the 
mouthpiece (15 mm long, 22 mm diameter) using 5 g of calcium chloride. 
 
Figure 4.6: Desiccation efficiency simulated as function of tube geometry for volumetric 
flow rate of 6.7 L.min
-1
. 
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4.3.2 Experimental validation of mouthpiece performance:  
In order to validate the flow simulation, mouthpieces with three different lengths 
and 22 mm diameter were prepared. This geometry was chosen for easy integration with 
our device. Figure 4.7 shows the comparison of simulated to measured pressure 
difference across the tube for the three chosen lengths. Both results correlate well 
showing that the pressure drop increases with increasing length of the mouthpiece. 
 
Figure 4.7: Comparison of simulated and experimentally measured pressure difference 
across the mouthpiece packed with 1.15 mm particles with a porosity of 0.425. 
Table 4.2 shows a comparison of simulated and measured desiccation efficiencies 
for different mouthpiece geometries, packing and particle sizes. Deviations in the results 
increase at high desiccation efficiencies. With increasing desiccation, the experimental 
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efficiency is lower than the predicted efficiency from the model. This could be attributed 
to the exothermic nature of the desiccation process which starts to affect the efficiency 
for high humidity capture. Due to higher surface temperature the actual efficiency of 
capture is lower as observed in the experimental results.  
Table 4.2: Comparison of simulated and measured desiccation efficiencies with different 
parameters of mouthpiece construction. 
Length 
(mm) 
Diameter 
(mm) 
Particle 
size 
(mm) 
Porosity 
Simulated  
efficiency 
Measured  
efficiency 
Difference 
in 
Efficiency 
12 22 1.15 0.425 44.1 % 43.6 % 0.5 % 
25 22 1.15 0.425 68.8 % 66.49 % 2.31 % 
49 22 1.15 0.425 89.3 % 81.54 % 7.76% 
12 22 0.65 0.365 58.5 % 61 % 2.5% 
15 22 0.65 0.365 69.6 % 68.4 % 1.2 % 
 
Figure 4.8 shows humidity output of the mouthpiece over ten successive 
breathings measured by SIFT-MS. Each exhalation was followed by purging with dry air 
sample. It can be observed that the output was much drier initially and the efficiency of 
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the mouthpiece decreased with successive breathing cycles due to exhaustion and heating 
although the average humidity remained within the desired non condensing levels. 
 
Figure 4.8: Humidity output of the mouthpiece (15 mm diameter, 30 mm length, 5 g 
calcium chloride, 1.15 mm particle diameter, porosity 0.425) for ten successive 
breathings. The baseline was obtained with dry air purging. 
4.3.3 Integration with portable breath sensors  
Desiccant mouthpiece with an efficiency of 70% (30 s sampling at 6.67 ml.min
-1
) 
was used to sample breath in colorimetric optical sensor developed in our lab. Figure 4.9 
(A) shows the response of the sensor to breath sampling without the mouthpiece. A jump 
in the intensity of signal can be observed in the sensing photodiode due to humidity 
condensation on the substrate affecting the transmittance [164]. Also, the reference 
photodiode shows random fluctuations in the signal. Response of the same sensor after 
integration of the mouthpiece is shown in Figure 4.9 (B). A linear decrease in intensity 
due to color development is observed without any spike due to humidity on the sensing 
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photodiode. The reference photodiode also shows a stable signal and fluctuations due to 
humidity are not observed. After integration of the mouthpiece, real breath samples could 
be analyzed for nitric oxide using the portable device as shown in Figure 4.10. 
 
Figure 4.9: Optical response from photodiodes used for detection of color change 
(sampling) and correction (reference) in intensity during breath test (A) without the use 
of desiccant mouthpiece and (B) after integration of the desiccant mouthpiece. 
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Figure 4.10: Analysis of nitric oxide levels in breath sample using colorimetric optical 
sensor integrated with the desiccation mouthpiece for online sample conditioning. A 
linear response is obtained towards nitric oxide. 
4.3.4 Selectivity of the desiccation material: 
The desiccation mouthpiece made of calcium chloride was tested for capture of 
some other gases including acetone, carbon dioxide, nitric oxide and oxygen for which 
the mouthpiece showed a capture efficiency of less than 5% for a 70% removal of 
humidity (Figure 4.11). These results show that the desiccant material can be used for 
analysis of these gases in conditioned breath by suitable sensors. However, there are 
some gases which can be captured by calcium chloride along with humidity. Ammonia is 
known to form complex with calcium chloride [165]. 10 ppmV input ammonia reduced to 
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0.8 ppmV output resulting in 92% ammonia removal efficiency of the calcium chloride 
mouthpiece under similar configuration. 
 
Figure 4.11: (A) Selective removal of humidity by the desiccant mouthpiece over other 
components of interest. (B) Absolute value of concentrations for different compounds 
tested before and after passing through the mouthpiece. 
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4.3.5 Reusability of the mouthpiece: 
Reusability of the mouthpiece was tested for conditioning of real samples. Figure 
4.12 (A) shows the efficiency of desiccation with variation of 5.6% at a mean efficiency 
level of 67.3% using a single mouthpiece for collection of ten samples with gap of 
10mins between successive tests. Each sample was collected at a flow rate of 6.7 L.min
-1
 
to fill a 4 L tedlar bag. A gap of 10 min was given between each collection which was 
necessary to avoid efficiency loss due to overheating of the tube. The desiccation tube 
was also used for routine testing over a week. A single mouthpiece was used for sample 
collection, two times a day separated by 6 to 8 hours for six consecutive days. Figure 
4.12 (B) shows the desiccation efficiency of each test. The mean efficiency for the six 
day test was 67.17% with a variation of 3.4%. The mouthpiece was stored in a regular 
zip-lock bag after each test. The storage was necessary because calcium chloride being 
hygroscopic adsorbs water continuously from the atmosphere. The zip-lock bag insulated 
the mouthpiece from the environment and avoided excessive humidity capture, which 
slowed the exhaustion of the mouthpiece.  
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Figure 4.12: (A) Efficiency and reusability of one mouthpiece with 10 mins gap between 
successive tests. Mean desiccation efficiency (%) was 67.3 % and variation from the 
mean was 5.6 % (B) Reusability of one mouthpiece over a week measured two time each 
day and stored in plastic zip lock bag. 
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4.4 Conclusions  
A miniaturized mouthpiece was developed to efficiently remove humidity and 
condition real breath samples in real time without affecting target analyte concentrations. 
The mouthpiece consists of packed desiccant particles in a tube. Numerical simulation of 
the desiccation process was carried out by taking into account various processes, 
including diffusion, mass transport and water absorption, described by differential 
equations with appropriate boundary conditions. The performance the mouthpiece in 
terms of humidity control and backpressure minimization depends on the size and 
packing density of the particles, geometry of the tube and flow rate. Based on the 
simulation, mouthpieces with different configurations were built and tested, and the 
experimental results validated the simulation findings. The findings provide guidance for 
those who wish to design efficient sample conditioning systems for practical chemical 
sensors, particularly breath analyzers. The mouthpiece was integrated into a handheld 
sensor for exhaled nitric oxide detection, and the results are in excellent agreement with 
gold standard methods. The miniaturized mouthpiece has great applicability for the new 
generation of portable breath analyzers, which require easy, efficient and reproducible 
removal of high humidity for seamless device functioning 
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5 
SENSOR FOR DETECTION OF ACETONE IN EXHALED BREATH 
5.1 Introduction 
Acetone is one of the three ketone bodies found in our blood. These ketone bodies 
include acetoacetate (AcAc), which is generated during fatty acid metabolism in the liver, 
3-β-hydroxybutyrate (3HB), which is formed by reduction of AcAc in the mitochondria 
and acetone, which is generated as a result of spontaneous decarboxylation of AcAc 
(Figure 5.1)  [166, 167].  
 
Figure 5.1: Ketone bodies in the blood 
The process of production of ketone bodies is called ketogenesis which takes 
place in mitochondria of liver cells [168, 169]. The liver can produce up to about 185 g of 
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ketone bodies in healthy adults per day. The process starts with β-oxidation of fatty acids 
to acetyl CoA which is converted to acetoacetyl CoA catalyzed by 3-ketothiolase. 
Acetoacetyl CoA is then converted to 3-hydroxy-3-methylglutaryl CoA (HMG CoA) by 
mitochondrial HMG CoA synthase. This step is stimulated by starvation, low levels of 
insulin, and consumption of a fat rich diet [170]. HMG CoA is cleaved by HMG CoA 
lyase to release AcAc which is reduced to 3HB by 3-hydroxybutyrate dehydrogenase 
(HBD). This reduction is accompanied by oxidation of NADH to NAD
+
. Thus, the ratio 
of 3HB to AcAc in the blood depends on the ratio of NADH/NAD
+
 in the hepatic 
mitochondria. These ketone bodies serve as fuel when glucose is not readily available 
[171] and reduce proteolysis [172, 173]. Being short chain organic acids, ketone bodies 
can freely diffuse across cell membranes [174, 175]. For this reason, brain which cannot 
utilize fatty acids for energy is dependent on ketone bodies for energy in case of glucose 
depletion. Ketone bodies supply about 2/3 of the brain’s energy needs during prolonged 
fasting and starvation [176]. A schematic of relationship of glucose and fatty acid 
metabolism leading to formation of ketone bodies in liver cells is shown in Figure 5.2. 
Acetyl CoA which is the common metabolite after glycolysis of glucose or β-oxidation of 
fatty acids condenses with oxaloacetate to enter the citric acid cycle. Oxaloacetate is 
derived from pyruvate during glycolysis by the action of pyruvate decarboxylase. 
Therefore, for acetyl CoA to enter the citric acid cycle a sufficient level of glycolysis is 
required. If body is depleted of glucose then oxaloacetate is preferentially utilized in 
glucose generation by gluconeogenesis, instead of condensing with acetyl CoA. Acetyl 
CoA is then diverted to ketone body formation. 
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Ketosis is the state characterized by elevated levels of ketone bodies in the body. 
Hyperketonemia which is elevated concentration of ketone bodies in the blood and 
ketoacidosis which results into decrease in blood pH due to excessive accumulation of 
ketone bodies in the blood can result from ketosis. Ketosis can be caused both by 
physiological and pathological processes. 
 
Figure 5.2: Ketone body production in hepatocytes [177]. 
Physiological processes which mainly result into hyperketonemia include fasting, 
prolonged exercise, or consumption of fat rich ketogenic diets. Fasting in adults may 
result into mild increase in ketone bodies. Ketone concentrations may rise above 1.0 mM 
after a fast of 3 days and reaching a plateau of 6-8 mM after 4 weeks of starvation. In 
newborn infants, ketosis may occur due to fasting resulting from non-availability of food. 
This could be caused by mild infections usually associated with vomiting and diarrhea 
[178]. Ketone levels in such conditions may rise up to 1 mM. Ketogenic diets commonly 
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used for weight loss programs [179, 180] treating epileptic children [181, 182] and 
prolonged exercise also result in physiological ketosis in which ketone body levels rise in 
the range of 1-2 mM [183, 184]. Pathological processes resulting in ketosis include 
diabetes mellitus, cortisol and growth hormone deficiency, toxic ingestions of ethanol or 
salicylates and certain rare inborn errors of metabolism. Of these, the most common 
causes of ketosis are diabetic ketoacidosis (DKA) and toxic ketoacidosis. DKA generally 
happens in type 1 diabetic patients but is also reported in type 2 diabetic patients [185, 
186]. DKA is characterized by uncontrolled hyperglycemia, metabolic acidosis, and 
increased total body ketone concentrations. DKA is dangerous compared to ketosis in 
normal people because insulin deficiency combined with hormonal imbalance i.e. 
increased levels of counter regulatory hormones (catecholamine, cortisol, glucagon, and 
growth hormone) leads to release of free fatty acids into circulation and uncontrolled 
oxidation by liver cells [187, 188]. In normal people insulin serves as a check on 
uncontrolled ketosis. DKA is a life threatening complication of diabetes. It is responsible 
for more than 500,000 hospital days per year and an estimated direct and indirect medical 
expense of 2.4 billion USD in United States [189-192]. 
Measuring blood or urine ketone levels is recommended for monitoring ketosis 
due to both physiological reasons like ketogenic diet [193] and pathological reasons like 
DKA [194, 195]. Most commonly used methods for measuring ketone bodies include 
urine dipsticks and electrochemical capillary blood monitors. Urine dipsticks utilize the 
nitroprusside reaction producing purple color upon complex formation with AcAc. This 
gives a semi-quantitative measure of AcAc and to some extent measure acetone with the 
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use of glycine but does not indicate 3HB [196]. Monitoring 3HB levels is of importance 
because during DKA the ratio of 3HB to AcAc changes from 1:1 to about 10:1. So, 
monitoring AcAc alone does not indicate the overall ketosis state. Laboratory analysis of 
3HB includes enzymatic assays which are time consuming and cannot be used for 
emergency diagnosis and management of DKA. Electrochemical sensors are available, 
for example Precision XtraTM (Abbott Diabetes Care, Inc. CA, USA), which measure 
electrical current proportional to 3HB concentrations in blood [197]. This method is 
currently approved and is used both at home and clinical settings [198]. 
Though, currently methods exist for monitoring ketosis they suffer from several 
drawbacks of being qualitative, slow in response to change in blood ketone or invasive. 
Breath acetone has been shown to be a reliable indicator of ketosis and it correlates with 
the levels of AcAc and 3HB in the blood [199, 200]. Studies have shown higher levels of 
breath acetone in diabetic patients compared to normal controls [59, 201]. Breath acetone 
has also been used for identification of diabetes [202]. A portable breath acetone sensor 
would not only help in non-invasive monitoring of ketosis which is valuable for 
managing DKA but it will also be useful for monitoring outcomes of diet regiments and 
exercise routines for weight management and epilepsy control. This chapter outlines 
efforts made towards development of such a platform utilizing colorimetric response of a 
pH indicator upon reaction of acetone with hydroxylamine acid salt. An overall approach 
of sensor development with sample conditioning and data analysis is presented. 
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5.2  Experimental 
5.2.1 Detection setup 
The detection setup similar to that developed for nitric oxide sensor based on 
optical detection of a colorimetric reaction was used. The setup used two photodiodes, 
one of the photodiodes captured light transmitted through chemically modified substrate 
which provided signal from the chemical change whereas the other photodiode captured 
light transmitted through the reference region devoid of chemical modification (Figure 
5.3). Photodiode readings from both the sensing and the reference regions were used to 
calculate the change in absorbance.  
 
Figure 5.3: Schematic representation of acetone detection setup. 
5.2.2 Artificial gas samples 
Artificial gas samples were prepared by injecting 100 μl of acetone solution into a 
4 L metal laminated tedlar bag filled with breathing grade air (Praxair, Inc.). Appropriate 
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volume of this high concentration acetone sample was injected in a bigger 40 L metal 
laminated tedlar bags filled with humidified air. Humidity and acetone concentrations 
were quantified in the bags using MIM mode of SIFT MS. The bigger bags were diluted 
or concentrated based on the quantification results to achieve the desired concentration.  
5.2.3 Chemical reaction 
The detection chemistry for acetone detection was based on pH change of based 
on Figure 5.4.  
 
Figure 5.4: Acetone reaction with hydroxylamine acid salt.  
The change in pH due to the released acid was measured by the colorimetric 
response of thymol blue 555 nm. 
5.2.4 Sampling of breath 
Offline collection of breath samples was done in 4 L metal laminated tedlar bags. 
The subject used a non-rebreathing T-valve (VacuMed, Part# 1464) to breathe into the 
bag without any flow regulation. For online breath samples, a desiccation tube was 
integrated with the non-rebreathing T-valve. The pressure difference was correlated with 
the flow rate measured with a digital mass flow meter (Sensirion, EM1). During breath 
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sampling the flow rate was integrated over time using an in house built microcircuit and 
processing software to indicate completion of 4 L of sampling. 
5.3 Results and discussions 
5.3.1 Sample regulation 
Breath samples were collected in real time by allowing subjects to blow directly 
into the device. The volume of the sample delivered to the device was fixed at 4 L. This 
was done by measuring pressure difference along the sampling line. The pressure 
difference was correlated with the flow rate (Figure 5.5) in a range of 0.5 to 10 L.min
-1
 
within which most of the subjects would blow into the device. The correlation graph was 
implemented through hardware developed in CBB to indicate the user when the target 
sampling volume was reached. The mean value of 4 L was achieved with a 3% 
coefficient of variation as shown in Figure 5.6. 
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Figure 5.5: Relationship between the sample flow rate and the pressure difference along 
the sampling line. The relationship was used to reach a target volume by measuring the 
pressure difference while sampling. 
 
Figure 5.6: Volume sampled into the device at different sample flow rates. The mean 
sampled volume was 4 L and the coefficient of variation was 3%. 
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5.3.2 Sensor calibration  
Response of the sensor towards acetone was measured in a range from 0.5 ppmV 
to 100 ppmV. This wide range of concentrations was chosen to reflect a broad range of 
breath acetone levels expected for normal subjects as well as diabetics and individuals 
under ketogenic diets [58, 203, 204]. As shown in Figure 5.7(A), the response to acetone 
was linear in lower concentration range up to 20 ppmV. Figure 5.7(B) shows the response 
of the acetone sensor at higher concentrations, which followed a non-linear Langmuir-
like behavior. Langmuir equation was used to fit the sensor response, with a resulting 
squared-correlation coefficient (R
2
) of 0.995. It is worth noticing that five tests were 
performed at each concentration, and relatively reproducible results were obtained (error 
bars represent standard deviation from 5 tests). 
 
Figure 5.7: Sensor calibration: (A) Linear response observed for acetone concentration up 
to 20 ppmV. Calibration slope = 0.00362± 0.00009 Absorbance (AU) / Acetone 
(ppmV) (intercept = 0) with a correlation coefficient of 0.997. (B) Overall response up to 
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100ppmV fitted on Langmuir equation curve Absorbance (AU) = 0.19X/( 36.57 + 
Acetone (ppmV)) with a correlation coefficient of 0.995. 
5.3.3 Correlation with SIFT-MS 
The sensor was used to measure acetone concentration in breath of three fasting 
subjects and the data was correlated with measurements from SIFT-MS. Figure 5.8 shows 
the correlation plot of the data obtained with a correlation coefficient of 0.96 and slope of 
1. The data was normalized by the total exhalation time taken to reach the target sample 
volume. 
The limit of agreement between the acetone sensor and SIFT-MS was determined 
from Bland-Altman plot as shown in Figure 5.9. The difference between the readings 
from acetone sensor and corresponding reading from SIFT-MS was plotted against the 
average reading from SIFT-MS and the acetone sensor. The limit of agreement was ±1.96 
standard deviations from the mean which was within 1 ppmV. This means that within 
95% confidence the reading from the sensor is within 1 ppmV difference from the 
reading obtained from SIFT-MS. 
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Figure 5.8: Correlation of the acetone sensor with SIFT-MS. Coefficient of correlation 
was 0.96 and slope was 1. 
 
Figure 5.9: Bland-Altman plot showing limit of agreement between acetone sensor and 
SIFT-MS to be within 1 ppmV. 
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5.3.4 Reproducibility of sensors 
Sensor responses were tested for variability both in intra and inter batch 
preparation. Figure 5.10 shows response of 60 sensors towards 4 ppmV acetone prepared 
in eight different batch. Coefficient of variation within a single batch was less than 15%. 
Overall mean of the normalized signal obtained for 60 sensors tested was 0.0129 with a 
17% coefficient of variation. 
 
Figure 5.10: Normalized signal towards 4 ppmV acetone of 60 sensors prepared in 8 
different batches. 
5.3.5 Monitoring Ketosis 
In order to test the capability of the sensor device for monitoring breath acetone release 
associated to ketone levels, two subjects were tested. Subject 1 was measured while the 
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ketone levels were building up during fasting. As shown in Figure 5.11(A), Subject 1 had 
a breath acetone level of 2.4 ppmV in the morning and reached a value of 6.6 ppmV after 
8 hours of fasting during the day. This trend was expected according to previous clinical 
studies under similar conditions [55]. On the other hand Subject 2, prior to testing, had 
developed ketosis induced by fat rich ketogenic diet. Subject 2 had a high breath acetone 
concentration of 8 ppmV in the morning. Subject’s breath acetone levels were followed 
after intake of a carbohydrate rich meal. The breath acetone level of the subject decreased 
from 8ppmV to about 2 ppmV after 8 hours (Figure 5.11(B)) as expected due to clearance 
of ketones induced by replacement of lipolysis by glycolysis. These tests clearly 
demonstrated the utility of the developed sensor in monitoring ketone buildup and 
clearance.  This would be useful both in monitoring the development of state of ketosis or 
onset of ketoacidosis and its effective treatment. 
 
Figure 5.11: Breath acetone levels assessed in individuals under fasting/diet-induced 
ketosis. (A) Monitoring breath acetone of Subject 1 building ketones during the fasting 
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period. (B) Monitoring breath acetone of Subject 2 during ketone clearance after intake of 
carbohydrate rich diet after ketogenic diet intake. 
5.4 Conclusions 
In conclusion, a colorimetric sensor for acetone measurement in exhaled human 
breath has been developed. Strategies to overcome confounding effect of humidity 
interference have been implemented. Analysis of real breath samples with subjects 
directly blowing into the sensor without the use of a pump for sample collection has been 
shown. The developed sensor has reproducible and stable response to be useful for 
monitoring the state of ketosis and ketoacidosis. 
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6 
CONCLUSIONS AND FUTURE DIRECTIONS 
 The work presented in this thesis has demonstrated the development of portable 
sensors for detection of specific breath analytes. Nitric oxide and acetone were chosen for 
detection because of their importance in monitoring health and fitness status of the body. 
Nitric oxide correlates with lung inflation and acetone reflects the level of ketosis in the 
body. Colorimetric detection was chosen for the reason of simplicity and cost effective 
implementation. Specific colorimetric reactions suitable for detection of each analyte 
were chosen and optimized for sensitive detection. Platforms for optical detection of the 
color change were developed in a simple and cost effective setup. Issues in the sampling 
procedures were identified and a solution to condition the breath samples was developed. 
The variability in sampling and its effect on detection was discussed and addressed. The 
developed sensor’s applications were demonstrated by analyzing real breath samples 
from subjects directly blowing into the sensors. 
 This work can be extended in multiple directions. The developed sensor devices 
can be used to perform epidemiological studies. Portability, ease of use and mobile 
compatibility of the devices for data communication and processing make them ideal for 
conducting such studies in free living conditions which is difficult otherwise. Another 
future work from device point of view could be to integrate multiple analyte detection 
into one device. Since both nitric oxide and acetone sensors utilize optical detection, they 
could share the same hardware. Though, there are several challenges which include 
different sampling and detection requirements, in principle this can be achieved. 
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Otherwise, chemistries can be developed to detect other analytes of importance in the 
breath which can use the developed optical detection platform. For example, ammonia for 
monitoring renal diseases and sulfides for monitoring liver health could be explored. The 
developed sensors could be integrated with other physical sensors to monitor 
physiological parameters such as heart rate, or body fat. These sensors can also be 
integrated with appropriate sampling techniques and optimized for environmental 
monitoring at a personal level. 
 Given the immense potential of breath sensing in disease diagnosis, monitoring 
and management I believe that such portable sensors will attract more attention in the 
future. More and more such sensors will come out of the lab space and be available as 
affordable products to serve the needs of the society.  
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